Oueslati, S.; Bogaerts, P.; Dortet, L.; Bernabeu, S.; Ben Lakhal, H.; Longshaw, C.; Glupczynski, Y.; Naas, T.
In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium. Antibiotics 2022, 11, 1352.
https://doi.org/10.3390/antibiotics11101352
AMA Style
Oueslati S, Bogaerts P, Dortet L, Bernabeu S, Ben Lakhal H, Longshaw C, Glupczynski Y, Naas T.
In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium. Antibiotics. 2022; 11(10):1352.
https://doi.org/10.3390/antibiotics11101352
Chicago/Turabian Style
Oueslati, Saoussen, Pierre Bogaerts, Laurent Dortet, Sandrine Bernabeu, Hend Ben Lakhal, Christopher Longshaw, Youri Glupczynski, and Thierry Naas.
2022. "In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium" Antibiotics 11, no. 10: 1352.
https://doi.org/10.3390/antibiotics11101352
APA Style
Oueslati, S., Bogaerts, P., Dortet, L., Bernabeu, S., Ben Lakhal, H., Longshaw, C., Glupczynski, Y., & Naas, T.
(2022). In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium. Antibiotics, 11(10), 1352.
https://doi.org/10.3390/antibiotics11101352